Your browser doesn't support javascript.
loading
Passive immunotherapies for the next influenza pandemic.
Focosi, Daniele; Franchini, Massimo; Senefeld, Jonathon W; Joyner, Michael J; Sullivan, David J; Pekosz, Andrew; Maggi, Fabrizio; Casadevall, Arturo.
Affiliation
  • Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
  • Franchini M; Division of Hematology and Transfusion Medicine, Mantua Hospital, Mantua, Italy.
  • Senefeld JW; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Joyner MJ; Department of Kinesiology and Community Health, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
  • Sullivan DJ; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Pekosz A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Maggi F; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Casadevall A; National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Rome, Italy.
Rev Med Virol ; 34(3): e2533, 2024 May.
Article in En | MEDLINE | ID: mdl-38635404
ABSTRACT
Influenzavirus is among the most relevant candidates for a next pandemic. We review here the phylogeny of former influenza pandemics, and discuss candidate lineages. After briefly reviewing the other existing antiviral options, we discuss in detail the evidences supporting the efficacy of passive immunotherapies against influenzavirus, with a focus on convalescent plasma.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza, Human / Influenza A Virus, H7N9 Subtype Limits: Humans Language: En Journal: Rev Med Virol Journal subject: VIROLOGIA Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza, Human / Influenza A Virus, H7N9 Subtype Limits: Humans Language: En Journal: Rev Med Virol Journal subject: VIROLOGIA Year: 2024 Document type: Article Affiliation country: